Results 121 to 130 of about 1,293,750 (146)

The central cholinergic system as a therapeutic target in Parkinson's disease. [PDF]

J Parkinsons Dis
Miller SJ, Yue JS, Bozal SB, Logan R, Hafler BP.   +4 more
europepmc   +1 more source

The role of acetylcholine and its receptors in tumor immune regulation: mechanisms and potential therapeutic targets. [PDF]

Mol Cancer
Zhang C, Guo X, Wang Y, Zhang S, Wang Z.
europepmc   +1 more source

The sleep-wake cycle: molecular mechanisms, disorders, and therapeutic targets in the context of energy metabolism. [PDF]

Signal Transduct Target Ther
Li JK, Wang RY, Meng XY, Kang JS.
europepmc   +1 more source

<i>De Novo</i> Design in an M₁ Positive Allosteric Modulator Backup Program: The Discovery of VU6069863. [PDF]

ACS Med Chem Lett
Han C, Rathnayake U, Gregro AR, Engers JL, Presley CC, Schley ND, Thompson Gray AD, Bubser M, Cho HP, Rodriguez AL, Kramlinger VM, Boutaud O, Niswender CM, Jones CK, Engers DW, Lindsley CW.   +15 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The M3 Muscarinic Acetylcholine Receptor Promotes Epidermal Differentiation

Journal of Investigative Dermatology, 2022
Sergei Grando, Bogi Andersen, Shuman Liu
exaly  

The endegenous muscarinic acetylcholine receptor in oocytes is of the M subtype

European Journal of Pharmacology, 1988
J A Tonnaer
exaly  

Primary structure of porcine cardiac muscarinic acetylcholine receptor deduced from the cDNA sequence

FEBS Letters, 1986
Akito Maeda, Katsunori Sugimoto, Tai Kubo   +2 more
exaly  

Primary structure of porcine muscarinic acetylcholine receptor III and antagonist binding studies

FEBS Letters, 1988
Akito Maeda, Junichi Nakai, Tai Kubo
exaly